Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2003
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1323429A1 Preventives/remedies for emotional disorders
07/02/2003EP1323422A1 Pharmaceutical composition comprising midazolam for buccal administration
07/02/2003EP1322769A2 Protein phosphatases
07/02/2003EP1322762A2 Haemophilus influenzae antigens and corresponding dna fragments
07/02/2003EP1322760A2 G-protein coupled receptors
07/02/2003EP1322759A2 Potassium channel interactors and uses therefor
07/02/2003EP1322755A1 Human and mouse targeting peptides identified by phage display
07/02/2003EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
07/02/2003EP1322748A2 Stem cell differentiation-inducing promoter
07/02/2003EP1322673A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
07/02/2003EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES
07/02/2003EP1322641A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai
07/02/2003EP1322629A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists
07/02/2003EP1322622A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
07/02/2003EP1322621A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
07/02/2003EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators
07/02/2003EP1322617A1 Compounds and methods for modulation of estrogen receptors
07/02/2003EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1322593A1 O-substituted 6-methyl-tramadol derivatives
07/02/2003EP1322592A1 Substituted 1-aminobutan-3-ol derivatives
07/02/2003EP1322590A1 5-amino-1-pentene-3-ol substituted derivatives
07/02/2003EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/02/2003EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
07/02/2003EP1322336A1 Method of increasing testosterone and related steroid concentrations in women
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/02/2003EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
07/02/2003EP1322303A1 Delivery system for multi-pharmaceutical active materials at various release rates
07/02/2003EP1322300A1 Inhalation particles incorporating a combination of two or more active ingredients
07/02/2003EP1322299A2 Composition for the transdermal delivery of fentanyl
07/02/2003EP1322298A1 Pharmaceutical oxan preparation
07/02/2003EP1242092B1 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
07/02/2003EP1227825A4 Isolation and expansion of human marrow stromal cells
07/02/2003EP1224180B1 Substituted azoles
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
07/02/2003EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
07/02/2003EP1140861B1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
07/02/2003EP1045849B1 Purine derivatives having phosphodiesterase iv inhibition activity
07/02/2003EP1016664B1 Fused thiophene compounds and medicinal use thereof
07/02/2003EP0990655B1 Method for drying anhydrous paroxetine hydrochloride
07/02/2003EP0954292B1 Pharmaceutical formulations with delayed drug release
07/02/2003EP0944582B1 Ketobenzamides as calpain inhibitors
07/02/2003EP0894010B1 Denaturants for sympathomimetic amine salts
07/02/2003EP0810879B1 Preparation and use of a specific gaba-aalpha5 receptor ligand for treatment of alzheimer's disease
07/02/2003EP0740658B1 N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
07/02/2003EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
07/02/2003CN1427841A Novel crystal form of 9-substituted hypoxanthine derivatives
07/02/2003CN1427840A Azabicyclic carbamates and their use as alpha-7 nicotinic acetyl choline receptor agonists
07/02/2003CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments
07/02/2003CN1427835A Stepwise Alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
07/02/2003CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
07/02/2003CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
07/02/2003CN1427726A Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
07/02/2003CN1427720A Metabotropic glutamate receptor antagonists for treating tolerance and dependency
07/02/2003CN1427717A Hydrophilic/lipophilic polymeric matrix dosage for mulation
07/02/2003CN1426812A Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma
07/02/2003CN1426810A Anti alcoholic agent using alder as material and mfg. method thereof
07/02/2003CN1426808A Non Opium Chinese medicine for withdrawal drug taking and its making method
07/02/2003CN1426798A Life prolonging and root securing pill and its processing method
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/02/2003CN1113057C Quinoline derivatives
07/02/2003CN1112931C Anti-stress drugs and functional foods having anti-stress effects
07/02/2003CN1112925C Neuroprotective agents
07/02/2003CN1112923C Indazole carboxamides
07/01/2003US6586623 Thiol-based NAALADase inhibitors
07/01/2003US6586596 Acetylcholine enhancers
07/01/2003US6586592 Bis-arylsulfones
07/01/2003US6586582 Human GABA receptor proteins and polynucleotides encoding the same
07/01/2003US6586478 Methods and compositions for improving sleep
07/01/2003US6586475 5-chloro-N-(2-N,N-diethylamino)ethyl)-2- methoxy-4-(1-naphthoylamino)benzamide and prodrugs, used for prevention of neurodegenarative diseases such as Alzheimer's disease
07/01/2003US6586474 Amidino compounds useful as nitric oxide synthase inhibitors
07/01/2003US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
07/01/2003US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide
07/01/2003US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea
07/01/2003US6586441 Adenosine receptor ligands and their use in the treatment of disease
07/01/2003US6586437 (S)-hydroxynefazodone antipsychotic therapy
07/01/2003US6586436 Serotonergic agents
07/01/2003US6586435 Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
07/01/2003US6586432 Neurokinin-1 receptor antagonists
07/01/2003US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
07/01/2003US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders
07/01/2003US6586422 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine
07/01/2003US6586421 For therapy of central nervous system, including diseases, disorders, and conditions related to, such as anxiety, depression, hypertension, migraine, obesity, compulsive disorders, schizophrenia, autism, neurodegenerative disorders
07/01/2003US6586414 Treatment of cerebrovascular disease
07/01/2003US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a
07/01/2003US6586179 Human Eag2
07/01/2003US6585997 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
07/01/2003US6585993 Controlled release neurotoxin system
07/01/2003US6585958 Medicinal aerosol formulations
07/01/2003CA2256227C Method of treating psychiatric conditions
06/2003
06/26/2003WO2003052414A1 Screening method
06/26/2003WO2003052106A1 Method of screening compounds
06/26/2003WO2003052095A2 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
06/26/2003WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
1 ... 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 ... 1833